Insider · CIK 0001961100

Baumal Caroline

Reports to the SEC for 1 company · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001961100

Forms 4 and 5

Insider transactions

24 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-14	APLSApellis Pharmaceuticals, Inc.U Disposition from Tender	Chief Medical Officer	UDisposition from Tender	−86.5K sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc.A Award	Chief Medical Officer	AAward	+41.3K sh	—	—	41,250
2026-05-14	APLSApellis Pharmaceuticals, Inc.D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−41.3K sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc.A Award	Chief Medical Officer	AAward	+26.4K sh	—	—	26,396
2026-05-14	APLSApellis Pharmaceuticals, Inc.D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−26.4K sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc.D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−8,888 sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc.D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−12.7K sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc.D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−29.7K sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc. · Stock Option (right to buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−82.5K sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc. · Stock Option (right to buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−49K sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc. · Stock Option (right to buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−37K sh	—	—	0
2026-04-29	APLSApellis Pharmaceuticals, Inc.G Gift	Chief Medical Officer	GGift	−900 sh	—	—	86,525
2026-01-22	APLSApellis Pharmaceuticals, Inc.S Sale	Chief Medical Officer	SSale	−2,797 sh	$21.77	−$60.9K	86,527
2026-01-20	APLSApellis Pharmaceuticals, Inc.S Sale	Chief Medical Officer	SSale	−1,882 sh	$19.79	−$37.3K	89,324
2026-01-05	APLSApellis Pharmaceuticals, Inc.S Sale	Chief Medical Officer	SSale	−3,020 sh	$25.53	−$77.1K	91,206
2025-06-09	APLSApellis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+82.5K sh	$19.39	+$1.6M	82,500
2025-01-21	APLSApellis Pharmaceuticals, Inc.A Award	Chief Medical Officer	AAward	+39.6K sh	—	—	93,301.37
2025-01-17	APLSApellis Pharmaceuticals, Inc.S Sale	Chief Medical Officer	SSale	−1,853 sh	$29.96	−$55.5K	53,707.37
2025-01-06	APLSApellis Pharmaceuticals, Inc.S Sale	Chief Medical Officer	SSale	−2,816 sh	$33.81	−$95.2K	55,560.37
2024-01-16	APLSApellis Pharmaceuticals, Inc.A Award	Chief Medical Officer	AAward	+25.4K sh	—	—	58,376.37
2024-01-16	APLSApellis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+37K sh	$66.30	+$2.45M	37,000
2024-01-04	APLSApellis Pharmaceuticals, Inc.S Sale	Chief Medical Officer	SSale	−2,751 sh	$60.05	−$165K	32,931.37
2023-01-03	APLSApellis Pharmaceuticals, Inc.A Award	Chief Medical Officer	AAward	+35.5K sh	—	—	35,682.37
2023-01-03	APLSApellis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+49K sh	$50.28	+$2.46M	49,000

Recent filings

Accepted (ET)
May 144
Baumal Caroline0001193125-26-224577
SEC(opens sec.gov)
May 14
Baumal Caroline0001492422-26-000105
SEC(opens sec.gov)
Jan 234
Baumal Caroline0001492422-26-000061
SEC(opens sec.gov)
Jan 214
Baumal Caroline0001492422-26-000045
SEC(opens sec.gov)
Jan 64
Baumal Caroline0001492422-26-000016
SEC(opens sec.gov)
Jun 114
Baumal Caroline0001127602-25-017277
SEC(opens sec.gov)
Jan 214
Baumal Caroline0001127602-25-001612
SEC(opens sec.gov)
Jan 84
Baumal Caroline0001127602-25-001011
SEC(opens sec.gov)
Jan 174
Baumal Caroline0001127602-24-001432
SEC(opens sec.gov)

Companies

Apellis Pharmaceuticals, Inc.Chief Medical OfficerAPLS

Address

C/O APELLIS PHARMACEUTICALS, INC. 100 FIFTH AVENUE, 3RD FLOOR

WALTHAM, MA, 02451